Novem Group
MEDP icon

Novem Group’s Medpace MEDP Stock Holding History

Novem Group’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.33M Buy
2,127
+22
+1% +$12.9K 0.13% 138
2026
Q2 		$1.11M Buy
2,105
+139
+7% +$64.2K 0.11% 163
2026
Q1 		$944K Buy
1,966
+129
+7% +$66.1K 0.11% 182
2025
Q4 		$1.03M Sell
1,837
-1,101
-37% -$625K 0.12% 164
2025
Q3 		$1.51M Sell
2,938
-42
-1% -$18.3K 0.18% 103
2025
Q2 		$935K Buy
2,980
+56
+2% +$16.8K 0.12% 162
2025
Q1 		$891K Buy
2,924
+763
+35% +$257K 0.13% 161
2024
Q4 		$718K Buy
+2,161
New +$733K 0.1% 180

Other funds holding MEDP

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Riverbridge Partners
Riverbridge Partners Minneapolis, Minnesota $3.41B AUM 6.54% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Novem Group's MEDP Position: Q3 2026 in Review

Novem Group increased its Medpace (MEDP) stake by 1% in Q3 2026, buying an estimated $12.9K and bringing the position to 2,127 shares worth $1.33M. The position accounts for 0.13% of the portfolio, ranked #138.

Novem Group first reported a position in MEDP in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.51M in Q3 2025. 369 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Novem Group held 2,127 shares of Medpace worth $1.33M as of Q3 2026.
  • Novem Group bought 22 Medpace shares in Q3 2026, an estimated $12.9K.
  • Medpace made up 0.13% of Novem Group's portfolio in Q3 2026, its #138 holding.
  • Novem Group first reported a position in Medpace in Q4 2024 and has held it in 8 quarters since.
  • Novem Group's Medpace position peaked at $1.51M in Q3 2025.
  • 369 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Novem Group's 13F filing for Q3 2026, filed 19 Oct 2026.